Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches-Reference-Cited by-同舟云学术

Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches

Published:2021-03-02 Issue:7 Volume:51 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur. J. Clin. Invest.

Author:

Dongiovanni Paola¹,Paolini Erika¹²,Corsini Alberto²³,Sirtori Cesare R.²,Ruscica Massimiliano²^ORCID

Affiliation:

1. General Medicine and Metabolic Diseases Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milan Italy

2. Department of Pharmacological and Biomolecular Sciences Università degli Studi di Milano Milan Italy

3. Multimedica IRCCSSesto San Giovanni (MI) Milan Italy

Funder

Fondazione Cariplo

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13519

Reference244 articles.

1. Non-alcoholic fatty liver disease and cardiovascular disease: A still debated liaison

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

4. NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment;Targher G;Diabetes Metab,2020

5. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-dialyzable uremic toxins and renal tubular cell damage in CKD patients: a systems biology approach;European Journal of Medical Research;2024-08-09

2. Effects of a High Trans Fatty Acid Diet on Kidney-, Liver-, and Heart-Associated Diseases in a Rabbit Model;Metabolites;2024-08-08

3. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

4. Impact of silymarin‐supplemented cookies on liver enzyme and inflammatory markers in non‐alcoholic fatty liver disease patients;Food Science & Nutrition;2024-07-17

5. Triglyceride-Targeted Molecularly Imprinted Polymers Activate Lipophagy via Cargo Exchange for Nonalcoholic Fatty Liver Disease Treatment;ACS Applied Polymer Materials;2024-06-14